SCHEMBL10076294

SCHEMBL10076294

CCc1cc(CC)cc(NC(=O)CCC(=O)O)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 1/20 0.56
POLB P06746 2/20 0.54
LMNA P02545 1/20 0.54
KMT2A Q03164 1/20 0.50
BCHE P06276 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
MAPT P10636 1/20 0.49
CYP1A2 P05177 1/20 0.49
GFER P55789 1/20 0.48
KDM4E B2RXH2 2/20 0.48
ALDH1A1 P00352 1/20 0.48
HPGD P15428 1/20 0.48
TSHR P16473 1/20 0.48
HSD17B10 Q99714 1/20 0.48
HDAC3 O15379 2/20 0.48
HDAC4 P56524 2/20 0.48
HDAC1 Q13547 2/20 0.48
HDAC7 Q8WUI4 2/20 0.48
HDAC2 Q92769 2/20 0.48
HDAC10 Q969S8 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14075745 0.86 MAPT (0.49) CYP1A1POLBKMT2AL3MBTL1MAPT
SCHEMBL10076183 0.83 MAPT (0.71) POLBLMNAKMT2AL3MBTL1MAPT
SCHEMBL7825376 0.82 POLB (0.74) CYP1A1POLBLMNAKMT2ABCHE
SCHEMBL10076296 0.78 TERT (0.46) POLBLMNAKMT2AMAPTCYP1A2
SCHEMBL27942322 0.78 HDAC3 (0.64) CYP1A1POLBLMNAKMT2ABCHE
SCHEMBL10076299 0.75 MAPT (0.47) POLBKMT2AL3MBTL1MAPTKDM4E
SCHEMBL14075740 0.75 LMNA (0.54) CYP1A1POLBLMNAKMT2AL3MBTL1
SCHEMBL4763034 0.74 LMNA (0.57) CYP1A1POLBLMNAKMT2ABCHE
SCHEMBL7096264 0.73 RAB9A (0.60) POLBKMT2AL3MBTL1MAPTKDM4E
SCHEMBL19152237 0.73 L3MBTL1 (0.53) CYP1A1POLBLMNAKMT2ABCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8093231-B2 Sulfonylethyl phosphorodiamidates TELIK, INC. (US) 2012-01-10 US disclosed
US-8093231-B2 Sulfonylethyl phosphorodiamidates TELIK, INC. (US) 2012-01-10 US disclosed
US-20080039429-A1 SULFONYLETHYL PHOSPHORODIAMIDATES TELIK, INC. 2008-02-14 US disclosed
US-20080039429-A1 SULFONYLETHYL PHOSPHORODIAMIDATES TELIK, INC. 2008-02-14 US disclosed
US-7262182-B2 Sulfonylethyl phosphorodiamidates TELIK, INC. (US) 2007-08-28 US disclosed
US-7262182-B2 Sulfonylethyl phosphorodiamidates TELIK, INC. (US) 2007-08-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080039429-A1 SULFONYLETHYL PHOSPHORODIAMIDATES MTAP, TYMP, PHOSPHO1 CYP1A1 4849/4885POLB 3723/4885LMNA 3943/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.